Showing results (351-360 of 1,783) with videos related to
Sort By:
Pageof 179
Dermatology and Therapy|March 29, 2025
Single-Injection Options for Administering a 320 mg Dose of Bimekizumab: 2 mL Safety Syringe and Auto-injectorMichael Sebastian, Jerry Bagel, Bengt Hoepken, et al.Dermatology and Therapy|March 29, 2025
Randomized Phase IIa Trial of Purified Candida Antigen for Common Warts: Evaluating the Safety and Efficacy Across Multiple Dosing RegimensStacy R Smith, Robert E Esch, H S Nielsen, et al.Dermatology and Therapy|April 22, 2025
The Association Between Atopic Dermatitis and Select Disease Events in Adults in the United States: A Retrospective Cohort Study in the Optum Electronic Health Records DatabaseAdina R Lemeshow, Alexander Egeberg, Thomas Edwards, et al.Dermatology and Therapy|May 5, 2025
Local Corticosteroids for Alopecia Areata: A Narrative ReviewSamantha Gregoire, Basil McIntosh, Katherine Sanchez, et al.Dermatology and Therapy|April 17, 2025
Epidemiology and Burden of Pediatric Atopic Dermatitis in ChinaChien-Chia Chuang, Lydia Braham-Chaouche, Ryan Thomas, et al.Dermatology and Therapy|April 17, 2025
Prescribing and Dispensing of Oral Isotretinoin and Noncompliance with Recommendations in France before and during the COVID-19 PandemicAnaïs Havet, Aurélie Moskal, Cécile Payet, et al.Dermatology and Therapy|April 15, 2025
Long-Term Efficacy and Potential Predictors of Tralokinumab Dose Optimization in Elderly Patients: A Multicentre StudyFrancisco Javier Melgosa Ramos, Sergio Santos Alarcón, Jose María Sánchez Motilla, et al.Dermatology and Therapy|April 15, 2025
Management of Challenging Psoriasis Clinical ScenariosLinda Stein Gold, Andrew Alexis, Brad P Glick, et al.Dermatology and Therapy|June 15, 2023
Cotrimoxazole as a Preventative Intervention for Pneumocystis Pneumonia in Pemphigus Patients Treated with Rituximab: A Retrospective StudyHao-Chen Hsu, Po-Wei Huang, Yung-Tsu Cho, et al.Dermatology and Therapy|June 2, 2023
A Case of Concurrent Psoriasis and Hidradenitis Suppurativa Successfully Treated with TildrakizumabThomas DamsinPageof 179